Filing Details

Accession Number:
0001645113-21-000067
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-12 13:00:00
Reporting Period:
2021-05-10
Accepted Time:
2021-05-12 16:15:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645113 Novocure Ltd NVCR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1632237 Ely Benaim C/O Novocure Inc.,
20 Valley Stream Parkway, Suite 300
Malvern PA 19355
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2021-05-10 1,833 $47.56 35,092 No 4 M Direct
Ordinary Shares Disposition 2021-05-10 1,833 $189.65 33,259 No 4 S Direct
Ordinary Shares Disposition 2021-05-11 2,262 $180.12 30,997 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Options to Buy Ordinary Shares Disposition 2021-05-10 1,833 $0.00 1,833 $47.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,165 2029-05-07 No 4 M Direct
Footnotes
  1. Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.
  2. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  3. Fully vested as of the date hereof.